论文信息 - OP02 Ustekinumab versus adalimumab for induction and maintenance therapy in Moderate-to-Severe Crohn’s Disease: The SEAVUE study - 字舞流文

OP02 Ustekinumab versus adalimumab for induction and maintenance therapy in Moderate-to-Severe Crohn’s Disease: The SEAVUE study

B. Sands | E. Loftus | R. Panaccione | S. Danese | V. Jairath | P. Irving | E. Scherl | C. Gasink | M. Allez | W. Sandborn | S. Hanauer | E. Mihály | T. Kuehbacher | T. Hoops | J. Izanec | A. Greenspan | O. Shchukina | L. Gao | Christopher Gasink | James D. Lewis | Emese Mihály | Ellen J. Scherl | James D Lewis